Neuralstem Inc. (CUR)

1.69
NASDAQ : Health Technology
Prev Close 1.67
Day Low/High 1.57 / 1.74
52 Wk Low/High 1.50 / 24.40
Avg Volume 159.10K
Exchange NASDAQ
Shares Outstanding 2.10M
Market Cap 3.51M
EPS -6.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Insider Trading Alert - VLGEA, PACW And CUR Traded By Insiders

Insider Trading Alert - VLGEA, PACW And CUR Traded By Insiders

Stocks with insider trader activity include VLGEA, PACW and CUR

Biotech Stock Mailbag: Akebia, Neuralstem, Arrowhead

Biotech Stock Mailbag: Akebia, Neuralstem, Arrowhead

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Insider Trading Alert - CUR, LAYN And SPR Traded By Insiders

Insider Trading Alert - CUR, LAYN And SPR Traded By Insiders

Stocks with insider trader activity include CUR, LAYN and SPR

Insider Trading Alert - CUR, LLY And GGP Traded By Insiders

Insider Trading Alert - CUR, LLY And GGP Traded By Insiders

Stocks with insider trader activity include CUR, LLY and GGP

6 Stocks Under $10 Triggering Breakout Trades

6 Stocks Under $10 Triggering Breakout Trades

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

First Week Of November 20th Options Trading For Neuralstem (CUR)

First Week Of November 20th Options Trading For Neuralstem (CUR)

Investors in Neuralstem Inc saw new options begin trading this week, for the November 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Biotech Stock Mailbag: Neuralstem, Genfit, Intercept, Amarin

Biotech Stock Mailbag: Neuralstem, Genfit, Intercept, Amarin

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Neuralstem Stock Plunges After Latest Study on ALS Drug

Neuralstem Stock Plunges After Latest Study on ALS Drug

Neuralstem is providing an overly optimistic picture about its surgical stem-cell therapy for amyotrophic lateral sclerosis (ALS), the degenerative and fatal nerve disease.

First Week of April 17th Options Trading For Neuralstem (CUR)

First Week of April 17th Options Trading For Neuralstem (CUR)

Investors in Neuralstem Inc saw new options become available this week, for the April 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CUR options chain for the new April 17th contracts and identified one put and one call contract of particular interest.

Small but Positive Response to Fed

Traders get aggressive with 'junk' biotech.

Interesting CUR Put And Call Options For March 20th

Interesting CUR Put And Call Options For March 20th

Investors in Neuralstem Inc saw new options begin trading this week, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CUR options chain for the new March 20th contracts and identified one put and one call contract of particular interest.

First Week of August 21st Options Trading For Neuralstem (CUR)

First Week of August 21st Options Trading For Neuralstem (CUR)

Investors in Neuralstem Inc saw new options begin trading this week, for the August 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 231 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Neuralstem (CUR) Stock Rises Today as Brainstorm Cell Therapeutics Soars

Neuralstem (CUR) Stock Rises Today as Brainstorm Cell Therapeutics Soars

Shares of Neuralstem (CUR) continue to rise in morning trading Friday in sympathy with peer company Brainstorm Cell Therapeutics (BCLI), which touched a one-year high on Friday.

One Reason Neuralstem (CUR) Stock is Rising Today

One Reason Neuralstem (CUR) Stock is Rising Today

Shares of stem cell therapy developer Neuralstem (CUR) were up on higher-than-average volume in afternoon trading Wednesday in sympathy with peer company Brainstorm Cell Therapeutics (BCLI).

Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy

Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy

Given the usual hype surrounding small-cap biotechs, Brainstorm CEO Tony Fiorino is refreshingly candid about the company's chances of developing a stem-cell treatment to counter ALS symptoms.

This bull market is showing its age

This bull market is showing its age

Here's how I am positioning myself for a downturn.

3 Stocks Under $10 to Trade for Breakouts

3 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.

Interesting CUR Put And Call Options For September 20th

Interesting CUR Put And Call Options For September 20th

Investors in Neuralstem Inc saw new options become available this week, for the September 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CUR options chain for the new September 20th contracts and identified one put and one call contract of particular interest.

First Week of February 2015 Options Trading For Neuralstem (CUR)

First Week of February 2015 Options Trading For Neuralstem (CUR)

Investors in Neuralstem Inc saw new options begin trading this week, for the February 2015 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

This bull market is showing signs of age

This bull market is showing signs of age

Stop-loss orders helped minimize losses during recent downturn.

Slow and Boring ... Again

Upcoming news from the ECB and monthly jobs should shake things up.

Interesting CUR Put And Call Options For July 19th

Interesting CUR Put And Call Options For July 19th

Investors in Neuralstem Inc saw new options begin trading today, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CUR options chain for the new July 19th contracts and identified one put and one call contract of particular interest.

Interesting CUR Put And Call Options For June 21st

Interesting CUR Put And Call Options For June 21st

Investors in Neuralstem Inc saw new options begin trading this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CUR options chain for the new June 21st contracts and identified one put and one call contract of particular interest.

Five Stocks Poised to Make More Gains

Five Stocks Poised to Make More Gains

Here are five stocks we're watching that have technical setups for continued upside.

Why I'm bullish on 3D Systems despite pricey valuation

Why I'm bullish on 3D Systems despite pricey valuation

3D Systems is an expensive stock, but has big potential.

Interesting CUR Put And Call Options For November 22nd

Interesting CUR Put And Call Options For November 22nd

Investors in Neuralstem Inc saw new options begin trading this week, for the November 22nd expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

4 Stocks Under $10 Moving Higher

4 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

First Week of April 19th Options Trading For Neuralstem (CUR)

First Week of April 19th Options Trading For Neuralstem (CUR)

Investors in Neuralstem Inc saw new options become available this week, for the April 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CUR options chain for the new April 19th contracts and identified one put and one call contract of particular interest.

5 Biotech Stocks to Trade in February

5 Biotech Stocks to Trade in February

These biotech stocks scheduled to present at the BIO CEO conference could be poised for sharp spikes higher.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.

TheStreet Quant Rating: D- (Sell)